IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Mabvax Therapeutics Holdings I

CUSIP: 55414P108 | 4 institutional holders

Quarters

Q2 2016Q1 2016Q4 2015Q3 2015Q2 2015
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2016

Biomark Capital Management Co. LLC197,641
0.2% of portfolio›$119
Geduld E E20,000
0.0% of portfolio›$11
StyleTurnoverLocationFiled
Biomark Capital Management Co. LLC
197,641$1190.2%N/AN/AGreenwich, CT2016-08-12
Geduld E E
20,000$110.0%N/AN/ANew York, NY2016-08-08